Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Look Back at Jeffrey Ubben’s Presentation at the 8th Annual New York Value Investing Congress

Page 1 of 28

On October 2, 2012, ValueAct Capital‘s fearless leader Jeffrey Ubben made a presentation on Day 2 of the 8th Annual Value Investing Congress in New York. Entitled “Avoiding Complexity and the VAC Circle of Life”, Ubben discussed several aspects of his investment philosophy during his presentation as well as the lessons he had learned through his years of triumphs and failures managing his own firm, and prior to that, serving as a managing partner at Blum Partners, and managing the Fidelity Value Fund. Among other things, he touched on the importance of steering clear of complex, unfocused businesses, as just one failure of its many parts can drag the rest down with it. Ubben also touched on the need to avoid companies with bad governance, instead putting oneself in a favorable position from the start of an investment rather than behind the eight ball with a dearth of problems to fix and a recalcitrant management team to butt heads with. This is particularly relevant for Ubben, who takes activist positions in the majority of his investments and seeks to work closely with management and the board to facilitate positive change. VALUEACT CAPITALUbben laid out his bullish case for a handful of stocks during his presentation, including Motorola Solutions Inc (NYSE:MSI) and Valeant Pharmaceuticals Intl Inc (NYSE:VRX), each of which he remains heavily invested in today. His slideshow presentation, which you can find on the following pages, focused on two companies, Moody’s Corporation (NYSE:MCO) and CBRE Group Inc (NYSE:CBG). The bullish case for credit ratings agency Moody’s was particularly interesting given that Ubben’s own presentation pointed out his dislike of traditional financial stocks and hard-to-value assets. It was also notable for the fact that David Einhorn, who was shorting Moody’s (and had been for some time), had slammed the stock earlier in the same day during his own presentation at the same conference, noting that the company was facing numerous lawsuits among other issues.

Ubben pointed to Moody’s Corporation (NYSE:MCO)’s strong position and limited competition, as well as its potential for low double-digit revenue growth opportunities. He had first gone activist on Moody’s in July 2011, reporting ownership of 13.87 million shares at the time, a step up from the 11.05 million shares he held at the end of June of that year. He would increase that position to 17.34 million shares by the end of the third quarter of 2012 before beginning to sell out of the stake in the fourth quarter and then completely exit it during the first quarter of 2013.

What happened? For a longterm value investor like Ubben who was heavily touting the stock just months prior, not only at the New York Value Investing Congress, but also a month later at Invest for Kids Chicago, it seems a rather surprising turn of events to sell out of the stock completely. Did he meet resistance in the boardroom that caused a change of heart concerning the company’s governance or direction? As it turns out, Ubben’s long thesis on Moody’s Corporation (NYSE:MCO) was right, as shares have doubled in value over the past 27 months. One value investor who did hang on to Moody’s during that time is Warren Buffett, who still holds 24.67 million shares as of March 31.

Ubben does still hold a large position in CBRE Group Inc (NYSE:CBG), the other stock highlighted in his slideshow. He held 31.62 million shares at the end of the third quarter of 2012 and holds nearly the same position, 31.32 million shares, as of March 31 of this year. His long thesis has also proven to be wise in this case, as shares of CBRE Group have also more than doubled since the conference. Among other things, Ubben valued CBRE Group for its market leading position in a number of commercial real estate services, as well as the growing diversification of its revenue and the positive forecasted growth for the commercial real estate market. Blum Capital Partners, Ubben’s former employer, also remained high on CBRE Group Inc (NYSE:CBG) over the years and holds the second largest position in our database to this day, after Ubben himself.

Check out Ubben’s slideshow presentation from the 8th Annual Value Investing Congress in New York on the following pages.

Disclosure: None

Page 1 of 28

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!